![](/img/cover-not-exists.png)
Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung
Velcheti, V., Hida, T., Reckamp, K.L., Yang, J.C., Nokihara, H., Sachdev, P., Feit, K., Kubota, T., Nakada, T., Dutcus, C.E., Ren, M., Tamura, T.Volume:
72
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(17)30651-2
Date:
February, 2017
File:
PDF, 50 KB
english, 2017